Carcinoma hepatocelular y colangiocarcinoma intrahepático en pacientes con cirrosis hepática

Barra lateral del artículo

PDF

Contenido principal del artículo

Oscar Sabino Chirife Chaparro
Servicio de Radiodiagnóstico. Hospital Clínic de Barcelona. Universidad de Barcelona, España
Ramón Vilana Puig
Servicio de Radiodiagnóstico. Hospital Clínic de Barcelona. Universidad de Barcelona, España
Luis Bianchi Cardona
Servicio de Radiodiagnóstico. Hospital Clínic de Barcelona. Universidad de Barcelona, España
Concepción Bru Saumell
Servicio de Radiodiagnóstico. Hospital Clínic de Barcelona. Universidad de Barcelona, España

Resumen

.

##plugins.themes.bootstrap3.displayStats.downloads##

##plugins.themes.bootstrap3.displayStats.noStats##
Publicado: 10-12-2011
DOI: https://doi.org/10.51987/Rev.Hosp.Ital.B.Aires.v31i4.957

Detalles del artículo

Número

Vol. 31 Núm. 4 (2011): Revista del Hospital Italiano de Buenos Aires

Sección

Ateneo radiológico
Creative Commons License

Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-CompartirIgual 4.0.

Cómo citar

1.
Chirife Chaparro OS, Vilana Puig R, Bianchi Cardona L, Bru Saumell C. Carcinoma hepatocelular y colangiocarcinoma intrahepático en pacientes con cirrosis hepática. Rev Hosp Ital B.Aires [Internet]. 10 de diciembre de 2011 [citado 31 de julio de 2026];31(4):146-9. Disponible en: https://ojs.hospitalitaliano.org.ar/index.php/revistahi/article/view/957

Referencias

Yuen MF, Tanaka Y, Fong DY, et al. In-dependent risk factors and predictive score for the development of hepatocellular car-cinoma in chronic hepatitis B. J Hepatol. 2009;50(1):80-8.

Hammill CW, Wong LL. Intrahepatic cholan-giocarcinoma: a malignancy of increasing impor-tance. J Am Coll Surg. 2008;207(4):594-603.

Forner A, Reig ME, de Lope CR, et al. Cur-rent strategy for staging and treatment: the BCLC update and future prospects. Semin Liver Dis. 2010;30(1):61-74.

Yachimski P, Pratt DS. Cholangiocarcino-ma: natural history, treatment, and strategies for surveillance in high-risk patients. J Clin Gastroenterol. 2008;42(2):178-90.

Bruix J, Sherman M; American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma: an update. Hepa-tology. 2011;53(3):1020-2.

Bruix J, Sherman M, Llovet JM, et al. Clini-cal management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. J Hepatol. 2001;35(3):421-30.

Bruix J, Sherman M; Practice Guide-lines Committee, American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma. Hepatology. 2005;42(5):1208-36.

Forner A, Vilana R, Ayuso C, et al. Diag-nosis of hepatic nodules 20 mm or smaller in cirrhosis: Prospective validation of the non-invasive diagnostic criteria for hepatocellular carcinoma. Hepatology. 2008;47(1):97-104. Errata en: Hepatology. 2008;47(2):769.

Vilana R, Forner A, Bianchi L, et al. In-trahepatic peripheral cholangiocarcinoma in cirrhosis patients may display a vascular pat-tern similar to hepatocellular carcinoma on contrast-enhanced ultrasound. Hepatology. 2010;51(6):2020-9.

Chen LD, Xu HX, Xie XY, et al. Enhance-ment patterns of intrahepatic cholangiocarci-noma: comparison between contrast-enhanced ultrasound and contrast-enhanced CT. Br J Ra-diol. 2008;81(971):881-9.

Claudon M, Cosgrove D, Albrecht T, et al. Guidelines and good clinical practice recom-mendations for contrast enhanced ultrasound (CEUS) - update 2008. Ultraschall Med. 2008;29(1):28-44.

Chen LD, Xu HX, Xie XY, et al. Enhance-ment patterns of intrahepatic cholangiocarci-noma: comparison between contrast-enhanced ultrasound and contrast-enhanced CT. Br J Ra-diol. 2008;81(971):881-9.

Rimola J, Forner A, Reig M, et al. Chol-angiocarcinoma in cirrhosis: absence of contrast washout in delayed phases by mag-netic resonance imaging avoids misdiagno-sis of hepatocellular carcinoma. Hepatology. 2009;50(3):791-8.

Maetani Y, Itoh K, Watanabe C, et al. MR imaging of intrahepatic cholangiocarcinoma with pathologic correlation. AJR Am J Roent-genol. 2001;176(6):1499-507.